Previous Page  27 / 30 Next Page
Information
Show Menu
Previous Page 27 / 30 Next Page
Page Background

allied

academies

Journal of Biotechnology and Phytochemistry

Volume 1 Issue 3

Chemistry World 2017

Notes:

Page 47

November 13-15, 2017 Athens, Greece

7

th

World Congress on

Chemistry

Application of the ALA-SCAN method in drug

discovery and pharmacodynamics

Cenk A Andac

Istinye University-Istanbul, Turkey

I

n drug discovery and pharmacodynamics, alanine

scanning (ALA-SCAN) is a method used to determine the

contribution of an aminoacid residue (other than alanine

or glycine) to the stability or function of a given protein or

peptide. In addition, point-mutations to alanine (or glycine)

allows researches to determine essential/non-essential

interactions between the peptide/non-peptide ligands and

their receptors, which provide crucial information in drug

discovery. In vivo applications of the ALA-SCAN technique

involves site-directed mutagenesis or random mutations

constituted by PCR library, which may be costly. On the

other hand, a more cost-effective method of ALA-SCAN has

been computationally utilized in theoretical chemistry. Here,

specific examples for the in-silico version of the ALA-SCAN

technique applied in our computer-assisted drug development

laboratory will be given.

Biography

Cenk A Andac works as an Assistant Professor in the School of Pharmacy at

Istinye University-Istanbul,Turkey. He has completed his Master’s degree and

PhD work as the Faculty of Pharmacy at the University of Wisconsin-Madison,

WI, USA (UW-Pharmacy, USA). He had been involved in teaching Drug

Actions & Delivery, and Pharmaceutical Biochemistry & Biotechnology courses

at UW-Pharmacy, USA for four and half years. He has also taught Medical

Pharmacology courses as an assistant professor for three years in Medical

school in Turkey. His current researches are development of novel anticancer

agents inhibiting G-coupled receptors in cancer stem cells; development of novel

aminoglycoside antibiotics; determination of 3D structures of biological and

synthetic compounds by NMR techniques; computer-assisted drug development

by AMBER, CHARMM and Quantum mechanics; Pharmacokinetics and

Pharmacodynamics properties of drug-receptor interactions. He currently holds

a patent for a potentially active anti-cancer agent against breast cancer.

cenk_andac@yahoo.com

Cenk A Andac, J Biotech and Phyto 2017